
Laurel Biosciences Private Limited
Founded in 2012 and headquartered in Telangana, India.
Founded in 2012 and headquartered in Telangana, India.
K.V.Rangareddy, Telangana, India
+91-XXXXXXXXXX
U24100TG2012PTC084208
084208
Private Limited Indian Non-Government Company
16 Nov 2012
30 Sep 2016
31 Mar 2016
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chaitanya Medapudi ![]() | Director | 16-Nov-2012 | Current |
Rajitha Medapudi ![]() | Director | 16-Nov-2012 | Current |
Enhance accessibility to Laurel Biosciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2016, Laurel Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Chaitanya Medapudi and Rajitha Medapudi are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Laurel Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Laurel Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laurel Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Laurel Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records.
Laurel Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Hyderabad.
Chaitanya Medapudi was appointed as a Director was appointed as a Director on 16 Nov 2012 & has been associated with this company since 12 years 6 months .
Rajitha Kumari Medapudi was appointed as a Director was appointed as a Director on 16 Nov 2012 & has been associated with this company since 12 years 6 months .
Laurel Biosciences Private Limited was registered on 16 Nov 2012 with Roc Hyderabad & aged 12 years 6 months as per MCA records.
Laurel Biosciences Private Limited was incorporated on 16 Nov 2012.
The authorized share capital of Laurel Biosciences Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Laurel Biosciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Laurel Biosciences Private Limited is H.No. 1-120/233/10/304 Plot No.10&11 Flat No.304, Jasti Residency Venkataraya Nagar Colony Nizampet, Hyderabad, Telangana, India, 500090.
The corporate identification number (CIN) of Laurel Biosciences Private Limited is U24100TG2012PTC084208 and the company number is 084208 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Laurel Biosciences Private Limited was filed with the ROC on 31 Mar 2016.
Search company & director profiles for free and gain access to critical business data.